minimal Common Oncology Data Elements (mCODE) Implementation Guide
2.0.0 - STU 2

This page is part of the HL7 FHIR Implementation Guide: minimal Common Oncology Data Elements (mCODE) Release 1 - US Realm | STU1 (v2.0.0: STU 2) based on FHIR R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

: cancer-related-medication-admin-cyclophosphamide-jenny-m - TTL Representation

Raw ttl | Download


@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix sct: <http://snomed.info/id/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

# - resource -------------------------------------------------------------------

 a fhir:MedicationAdministration;
  fhir:nodeRole fhir:treeRoot;
  fhir:Resource.id [ fhir:value "cancer-related-medication-admin-cyclophosphamide-jenny-m"];
  fhir:Resource.meta [
     fhir:Meta.profile [
       fhir:value "http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-cancer-related-medication-administration";
       fhir:index 0;
       fhir:link <http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-cancer-related-medication-administration>     ]
  ];
  fhir:DomainResource.text [
     fhir:Narrative.status [ fhir:value "extensions" ];
     fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"cancer-related-medication-admin-cyclophosphamide-jenny-m\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-mcode-cancer-related-medication-administration.html\">Cancer-Related Medication Administration Profile</a></p></div><p><b>Procedure Intent Extension</b>: Curative - procedure intent (qualifier value) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#373808002)</span></p><p><b>status</b>: completed</p><p><b>category</b>: Outpatient <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.0.0/CodeSystem-medicationrequest-category.html\">MedicationRequest Category Codes</a>#outpatient)</span></p><p><b>medication</b>: cyclophosphamide <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.0.0/CodeSystem-v3-rxNorm.html\">RxNorm</a>#3002)</span></p><p><b>subject</b>: <a href=\"Patient-cancer-patient-jenny-m.html\">Patient/cancer-patient-jenny-m</a> \" M\"</p><p><b>effective</b>: 2018-04-22</p><h3>Performers</h3><table class=\"grid\"><tr><td>-</td><td><b>Actor</b></td></tr><tr><td>*</td><td><a href=\"Practitioner-us-core-practitioner-nancy-oncology-nurse.html\">Practitioner/us-core-practitioner-nancy-oncology-nurse</a> \" NURSE\"</td></tr></table><p><b>reasonReference</b>: <a href=\"Condition-primary-cancer-condition-jenny-m.html\">Condition/primary-cancer-condition-jenny-m</a></p><p><b>note</b>: cyclophosphamide (60 mg/m² IV), 932.59 mg in 50 ml 0.9% normal saline administered by continuous infusion. Patient tolerated infusion without side effects. (By Practitioner/us-core-practitioner-nancy-oncology-nurse @2018-04-22)</p><h3>Dosages</h3><table class=\"grid\"><tr><td>-</td><td><b>Route</b></td><td><b>Dose</b></td></tr><tr><td>*</td><td>Intravenous route (qualifier value) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#47625008)</span></td><td>932.59 mg<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code mg = 'mg')</span></td></tr></table></div>"
  ];
  fhir:DomainResource.extension [
     fhir:index 0;
     fhir:Extension.url [ fhir:value "http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-procedure-intent" ];
     fhir:Extension.valueCodeableConcept [
       fhir:CodeableConcept.coding [
         fhir:index 0;
         a sct:373808002;
         fhir:Coding.system [ fhir:value "http://snomed.info/sct" ];
         fhir:Coding.code [ fhir:value "373808002" ];
         fhir:Coding.display [ fhir:value "Curative - procedure intent (qualifier value)" ]       ]     ]
  ];
  fhir:MedicationAdministration.status [ fhir:value "completed"];
  fhir:MedicationAdministration.category [
     fhir:CodeableConcept.coding [
       fhir:index 0;
       fhir:Coding.system [ fhir:value "http://terminology.hl7.org/CodeSystem/medicationrequest-category" ];
       fhir:Coding.code [ fhir:value "outpatient" ]     ]
  ];
  fhir:MedicationAdministration.medicationCodeableConcept [
     fhir:CodeableConcept.coding [
       fhir:index 0;
       fhir:Coding.system [ fhir:value "http://www.nlm.nih.gov/research/umls/rxnorm" ];
       fhir:Coding.code [ fhir:value "3002" ];
       fhir:Coding.display [ fhir:value "cyclophosphamide" ]     ]
  ];
  fhir:MedicationAdministration.subject [
     fhir:Reference.reference [ fhir:value "Patient/cancer-patient-jenny-m" ]
  ];
  fhir:MedicationAdministration.effectiveDateTime [ fhir:value "2018-04-22"^^xsd:date];
  fhir:MedicationAdministration.performer [
     fhir:index 0;
     fhir:MedicationAdministration.performer.actor [
       fhir:Reference.reference [ fhir:value "Practitioner/us-core-practitioner-nancy-oncology-nurse" ]     ]
  ];
  fhir:MedicationAdministration.reasonReference [
     fhir:index 0;
     fhir:Reference.reference [ fhir:value "Condition/primary-cancer-condition-jenny-m" ]
  ];
  fhir:MedicationAdministration.note [
     fhir:index 0;
     fhir:Annotation.authorReference [
       fhir:Reference.reference [ fhir:value "Practitioner/us-core-practitioner-nancy-oncology-nurse" ]     ];
     fhir:Annotation.time [ fhir:value "2018-04-22"^^xsd:date ];
     fhir:Annotation.text [ fhir:value "cyclophosphamide (60 mg/m² IV), 932.59 mg in 50 ml 0.9% normal saline administered by continuous infusion. Patient tolerated infusion without side effects." ]
  ];
  fhir:MedicationAdministration.dosage [
     fhir:MedicationAdministration.dosage.route [
       fhir:CodeableConcept.coding [
         fhir:index 0;
         a sct:47625008;
         fhir:Coding.system [ fhir:value "http://snomed.info/sct" ];
         fhir:Coding.code [ fhir:value "47625008" ];
         fhir:Coding.display [ fhir:value "Intravenous route (qualifier value)" ]       ]     ];
     fhir:MedicationAdministration.dosage.dose [
       fhir:Quantity.value [ fhir:value "932.59"^^xsd:decimal ];
       fhir:Quantity.unit [ fhir:value "mg" ];
       fhir:Quantity.system [ fhir:value "http://unitsofmeasure.org" ];
       fhir:Quantity.code [ fhir:value "mg" ]     ]
  ].

# - ontology header ------------------------------------------------------------

 a owl:Ontology;
  owl:imports fhir:fhir.ttl.